US Patent 11084796 Heterocyclic derivatives for the treatment of RSV

Patent 11084796 was granted and assigned to GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.

Current Assignee

‌

GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110847960

Patent Inventor Names

Richard K. Plemper0

Elyse Bourque0

John Vernachio0

Eddy Lee0

Date of Patent

August 10, 2021

Patent Application Number

201705100

Date Filed

May 10, 2017

Patent abstract

Disclosed herein are compounds and compositions for treating or inhibiting RSV and related members of the pneumovirus and paramyxovirus families such as human metapneumovirus, mumps virus, human parainfluenzaviruses, and Nipah and hendra virus, and methods of treatment or prevention thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11084796 Heterocyclic derivatives for the treatment of RSV

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API